Jh. Cummings et al., IN-VIVO STUDIES OF AMYLOSE-COATED AND ETHYLCELLULOSE-COATED [C-13] GLUCOSE MICROSPHERES AS A MODEL FOR DRUG-DELIVERY TO THE COLON, Journal of controlled release, 40(1-2), 1996, pp. 123-131
The observation that certain starches naturally present in the diet re
sist pancreatic enzymes and reach the colon where they are fermented b
y bacterial amylases has been exploited to provide a coating for speci
fically targeting drugs to the human large intestine. A mixture of amy
lose, which is a fraction of starch that can be made resistant to panc
reatic enzymes, and Ethocel (1:4 amylose:Ethocel) has been developed a
nd [C-13]glucose used as a surrogate for drug delivery. Eight healthy
subjects were given, fasting, at 8 am amylose-Ethocel coated pellets c
ontaining 300 mg [C-13]glucose together with a further capsule that co
ntained amberlite resin labelled with Tc-99m to act as a transit marke
r and outline for the anatomy of the gut. Subjects underwent gamma-sci
ntigraphy at half-hourly intervals for 5 h and then at hourly interval
s until 8 pm. Breath samples were taken for (CO2)-C-13, which was meas
ured by gas isotope mass spectrometry, at half-hourly intervals for 5
h and then hourly until 2300 h, with two further breath samples the fo
llowing morning before breakfast. Gamma-scintigraphy showed that 5% of
the activity had arrived in the caecum at 3.5 h after oral dosage (ra
nge 2.5-4.75 h) with all the material in the colon after 7.1 h (4.5-10
h). Breath (CO2)-C-13 data were analysed by the cusum technique and b
y curve fitting to determine first appearance of (CO2)-C-13 in breath.
The first rise in breath (13)CO2 was at 3.5 h (range 2.0-6.0 h) with
1% accumulated recovery of breath (CO2)-C-13 at 6.2 h (5.2-7.3 h). Tot
al (CO2)-C-13 recovery at 25 h was 37.5% (21.9-47.8%). A single subjec
t given a dose of uncoated glucose showed a rise in breath (CO2)-C-13
at 30 min peaking at 1.5 h and a total recovery of 28% at 6 h. Accumul
ated recovery curves for (CO2)-C-13 in breath showed that pellet break
down and glucose metabolism was occurring over a 15 h period with a de
lay of about 2.7 h between arrival in the caecum and significant (1%)
breakdown of the pellets. Resistant amylose, a naturally occurring com
ponent of the diet combined with ethylcellulose, can therefore be used
to coat pellets that allow controlled release of contents for targete
d drug delivery to the large bowel during a 12-24 h period.